TruBridge (TBRG) AI Stock Analysis

• Market Cap: $288.37M
• Dividend Yield: N/A
• Average Volume (3M): 110.38K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.55
• Revenue Growth: 3.75%
• EPS Growth: N/A
• Country: US
• Employees: 3,200
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): 0.88
• Shares Outstanding: 15,011,642
• 10 Day Avg. Volume: 98,314
• 30 Day Avg. Volume: 110,375
• PEG Ratio: 0.25
• Price to Book (P/B): 1.67
• Price to Sales (P/S): 0.82
• P/FCF Ratio: 21.63
• Enterprise Value/Market Cap: 1.72
• Enterprise Value/Revenue: 1.42
• Enterprise Value/Gross Profit: 2.67
• Enterprise Value/Ebitda: 9.25
• 1Y Price Target: $21.00
• Price Target Upside: -0.52% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 1
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 59 Neutral
• Price Target: $21.00 ▼(-0.52% Downside)

TruBridge's overall stock score reflects strong revenue growth and cash flow improvements, which are offset by profitability challenges and a high P/E ratio indicating overvaluation. The earnings call provided a positive outlook on margin expansion, but concerns about bookings and Financial Health revenue persist. Technical indicators suggest a neutral trend, contributing to the moderate score.

Positive Factors

Revenue Growth

The robust top-line expansion indicates strong demand for TruBridge's services, positioning it well for future growth and market penetration.

Cash Flow Improvements

Improved cash flow and reduced debt enhance financial stability, providing TruBridge with greater flexibility for strategic investments and growth initiatives.

Cost Optimization

Effective cost management has led to margin improvements, which can enhance profitability and provide a competitive edge in the healthcare technology sector.

Negative Factors

Profitability Challenges

Persistent profitability issues could hinder TruBridge's ability to reinvest in growth and compete effectively, impacting long-term sustainability.

Underwhelming Bookings

Declining bookings suggest potential challenges in sales execution or market demand, which could affect future revenue growth and financial performance.

Challenges in Financial Health Revenue

Stagnant revenue in key segments may indicate competitive pressures or product limitations, potentially impacting TruBridge's market position and growth prospects.

TruBridge Business Overview & Revenue Model

Company Description

TruBridge, Inc. provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence. The company provides acute care solutions and related services for community hospitals, and physician clinics; and patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. In addition, it offers patient liability estimates eligibility verification, claim scrubbing and submission, remittance management, denial/audit management, and contract management; and offers RCM services, such as accounts receivable management, private pay service, medical coding, revenue cycle consulting, and other additional insurance and patient billing services. Further, it offers consulting and business management services; managed IT services; encoder solutions; patient management; financial accounting; clinical; patient care; and enterprise applications. Additionally, it offers TruBridge HER platform, including total system support, national client conference, continuing education, software releases, hardware replacement, cloud electronic health record, forms and supplies, and public cloud infrastructure services; post-acute care software systems, and support and maintenance services; and InstantPHR, an interactive portal and CHBase which funnels data from multiple sources into one platform. The company was formerly known as Computer Programs and Systems, Inc. and changed its name to TruBridge, Inc. in March 2024. TruBridge, Inc. was founded in 1979 and is headquartered in Mobile, Alabama.

How the Company Makes Money

TruBridge generates revenue primarily through its services in revenue cycle management and healthcare consulting. Key revenue streams include fees charged for software subscriptions, consulting services, and performance-based contracts with healthcare providers. The company also benefits from partnerships with technology providers and healthcare organizations, which can enhance its service offerings and expand its client base. Additionally, TBRG may earn revenue through training and support services for its clients, further solidifying its presence in the healthcare market.

TruBridge Financial Statement Overview

Summary

TruBridge exhibits strong revenue growth and improved cash flow generation, positioning it well for future expansion. However, profitability remains a concern with negative net margins and return on equity. The company's balance sheet shows reduced leverage, enhancing financial stability. Continued focus on improving profitability and operational efficiency will be crucial for sustaining growth.

Income Statement

TruBridge has shown a strong revenue growth rate of 65.5% in the TTM, indicating robust top-line expansion. However, the net profit margin remains negative at -1.59%, reflecting challenges in converting revenue growth into profitability. The gross profit margin is healthy at 57.67%, suggesting efficient cost management. EBIT and EBITDA margins are moderate at 5.55% and 7.83%, respectively, indicating room for improvement in operational efficiency.

Balance Sheet

The company's debt-to-equity ratio has significantly improved to 0.025 in the TTM, indicating reduced leverage and a stronger balance sheet. However, the return on equity is negative at -4.37%, highlighting profitability challenges. The equity ratio stands at 45.16%, suggesting a stable capital structure with a reasonable proportion of equity financing.

Cash Flow

TruBridge has achieved a substantial free cash flow growth rate of 43.05% in the TTM, demonstrating strong cash generation capabilities. The operating cash flow to net income ratio is high at 192.08, indicating efficient cash conversion. However, the free cash flow to net income ratio is relatively low at 0.21, suggesting potential reinvestment or debt repayment needs.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	349.88M	342.65M	339.44M	326.65M	280.63M	264.49M
Gross Profit	185.99M	174.12M	163.57M	160.11M	144.85M	136.25M
EBITDA	53.72M	34.94M	-15.39M	47.73M	43.11M	35.56M
Net Income	5.58M	-20.44M	-45.79M	15.87M	18.43M	14.25M
Balance Sheet
Total Assets	399.41K	394.43M	431.78M	430.96M	383.35M	326.27M
Cash, Cash Equivalents and Short-Term Investments	19.92K	12.32M	3.85M	6.95M	11.43M	12.67M
Total Debt	4.57K	174.81M	203.29M	147.24M	106.46M	83.43M
Total Liabilities	219.05K	225.74M	247.80M	199.25M	160.78M	126.27M
Stockholders Equity	180.36K	168.69M	183.97M	231.71M	222.57M	200.00M
Cash Flow
Free Cash Flow	29.43M	13.04M	-22.35M	13.01M	37.46M	42.48M
Operating Cash Flow	38.40M	32.13M	1.06M	32.38M	47.74M	49.14M
Investing Cash Flow	-12.63M	4.12M	-60.11M	-62.73M	-69.92M	-6.66M
Financing Cash Flow	-14.44M	-27.74M	55.95M	25.88M	20.93M	-37.16M

TruBridge Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 21.11
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TBRG, the sentiment is Positive. The current price of 21.11 is above the 20-day moving average (MA) of 19.66, above the 50-day MA of 20.13, and below the 200-day MA of 23.25, indicating a neutral trend. The MACD of 0.15 indicates Negative momentum. The RSI at 68.93 is Neutral, neither overbought nor oversold. The STOCH value of 81.47 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TBRG.

TruBridge Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SPOK	72 Outperform	$283.64M	17.21	10.88%	9.95%	1.47%	11.33%
NRC	68 Neutral	$317.82M	19.57	66.01%	3.62%	-3.50%	-37.46%
SLP	63 Neutral	$341.76M	―	-41.49%	0.35%	20.01%	-750.59%
OPRX	61 Neutral	$275.70M	―	0.03%	―	24.19%	―
TBRG	59 Neutral	$288.37M	-22.76	1.57%	―	3.75%	―
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
HCAT	45 Neutral	$158.44M	―	-31.33%	―	4.64%	-17.17%

TruBridge Corporate Events

TruBridge, Inc. Earnings Call: Mixed Sentiments and Optimistic Outlook

TruBridge, Inc.’s recent earnings call revealed a mixed sentiment, highlighting both achievements and challenges. The company showcased significant improvements in financial metrics, cost optimization, and cash flow, yet faced hurdles with underwhelming bookings and stagnant Financial Health revenue. Despite these challenges, TruBridge remains optimistic about future growth and margin expansion.

TruBridge, Inc. Reports Strong Q3 2025 Performance

TruBridge, Inc. is a prominent provider of revenue cycle management and healthcare technology solutions, primarily serving rural and community healthcare organizations. The company focuses on enhancing financial performance and maintaining the independence of healthcare providers in their communities.

TruBridge Appoints New Chief Business Officer

On October 1, 2025, TruBridge announced that Dawn M. Severance would step down as Chief Sales Officer by October 31, 2025, following the company’s decision to eliminate the position. Her departure is amicable and not due to any disagreements, and she will receive severance benefits as per her agreement. On October 3, 2025, TruBridge appointed Michael Daughton as Chief Business Officer, effective October 6, 2025, to enhance client-centered excellence and growth. Daughton, with 30 years of strategic healthcare leadership experience, is expected to drive shareholder value and reinforce TruBridge’s commitment to rural and community healthcare.

The most recent analyst rating on (TBRG) stock is a Hold with a $22.50 price target. To see the full list of analyst forecasts on TruBridge stock, see the TBRG Stock Forecast page.